Market Overview: In 2022, the global breast ultrasound market attained a value of USD 1.25 billion, and projections indicate a growth to USD 2.14 billion by 2032, accompanied by a steady revenue compound annual growth rate (CAGR) of 5.9%. The driving force behind this expansion is the increasing demand for early and accurate breast cancer diagnosis due to the rising prevalence of the disease worldwide. The World Health Organization (WHO) estimates that breast cancer will affect 2.3 million new cases globally in 2020, making it the most widespread cancer among women.
Factors Contributing to Revenue Growth: The market’s revenue surge is primarily attributed to the growing adoption of breast ultrasonography for cancer detection and screening. This non-invasive imaging technique utilizes sound waves to generate images of breast tissue, proving to be a safe and cost-effective screening method, particularly for women with dense breast tissue or those at high risk of breast cancer.
Request for Sample @https://www.reportsanddata.com/download-free-sample/6274
Sophisticated breast ultrasound devices equipped with features such as automated breast ultrasound and 3D imaging further propel market growth. These devices enhance the accuracy and visualization of breast cancer detection, encouraging healthcare professionals to embrace their use. Additionally, technological advancements like elastography and Contrast-Enhanced Ultrasonography (CEUS) contribute to market expansion by providing more precise diagnostic information.
Favorable reimbursement policies for breast ultrasonography screening and diagnosis in various countries, exemplified by the Affordable Care Act (ACA) in the U.S., further stimulate market growth.
Challenges and Restraints: Despite the positive outlook, challenges such as the high cost of breast ultrasound systems and the availability of alternative imaging modalities like Mammography and Magnetic Resonance Imaging (MRI) pose potential constraints. The scarcity of qualified healthcare workers capable of performing and interpreting breast ultrasound imaging also stands as a hindrance to market growth.
Government Regulations: Regulatory bodies in different regions, including the U.S. Food and Drug Administration (FDA), the European Union (EU), the Therapeutic Goods Administration (TGA) in Australia, the Ministry of Health, Labour and Welfare (MHLW) in Japan, and the Central Drugs Standard Control Organization (CDSCO) in India, impose standards and requirements on medical devices used in breast cancer diagnosis and treatment.
Product Outlook: The global breast ultrasound market is categorized into handheld and cart-based devices. Cart-based systems dominated the market in 2022, primarily due to their advanced features and technology, making them suitable for use in hospitals, diagnostic facilities, and healthcare institutions. However, the handheld segment is expected to experience the fastest revenue CAGR during the forecast period, driven by the demand for portable ultrasound systems in remote and rural locations and home healthcare settings.
End-use Outlook: End-use segmentation includes hospitals, diagnostic imaging facilities, ambulatory surgical facilities, and others. Hospitals led the market in 2022, driven by the substantial need for breast ultrasound services and the availability of innovative technology and qualified medical staff. Diagnostic imaging centers are anticipated to witness the fastest revenue CAGR, fueled by the increasing number of such facilities globally and the availability of advanced ultrasound technologies. Ambulatory surgical centers are also expected to experience significant growth due to the importance of breast ultrasonography in breast biopsies.
Regional Outlook: North America is anticipated to dominate the market throughout the forecast period, driven by the high incidence of breast cancer and well-established healthcare infrastructure. Europe is expected to hold a considerable revenue share, with the U.K. being a significant market. The Asia Pacific region is projected to witness the fastest revenue CAGR, attributed to the rising prevalence of breast cancer in countries like China and India, coupled with increased investments in healthcare infrastructure.
Competitive Landscape: The global breast ultrasound market is characterized by fragmentation, with numerous large and medium-sized players contributing to the majority of market revenue. Major players, including General Electric Company, Siemens Healthineers AG, Koninklijke Philips N.V., Hologic Inc., Fujifilm Holdings Corporation, and others, are implementing various strategies such as mergers and acquisitions, strategic agreements, and product development to maintain a competitive edge. Noteworthy strategic developments include Siemens Healthineers’ acquisition of Varian Medical Systems, Hologic Inc.’s acquisition of Somatex Medical Technologies GmbH, and Samsung Medison Co. Ltd.’s launch of the RS85 Prestige breast ultrasound system.
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/6274
Thank you for reading global report. We also offer customized research reports as per client requirement. Kindly contact us for to know more about the feature and our team will provide you a well-curated report in the stipulated time.
Explore Trending Reports:
Antifreeze Proteins Market-https://www.globenewswire.com/news-release/2020/04/13/2015157/0/en/Antifreeze-Proteins-Market-To-Reach-USD-11-1-Million-By-2027-Reports-and-Data.html
Food Enzymes Market-https://www.globenewswire.com/news-release/2019/09/19/1918190/0/en/Food-Enzyme-Market-To-Reach-USD-3-80-Billion-By-2026-Reports-And-Data.html
Wheat Protein Market-https://www.globenewswire.com/news-release/2019/09/19/1918180/0/en/Wheat-Protein-Market-To-Reach-USD-3-08-Billion-By-2026-Reports-And-Data.html
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a nconcrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press Release: https://www.reportsanddata.com/press-release